Precio de cierre
Otros sitios de cotización
|
||
- SEK | - |
2023 | Synokem Pharmaceuticals Limited adquirió a Recipharm AB (publ) una participación del 74% en Nitin Lifesciences Limited. | CI |
2023 | Recipharm anuncia cambios en su CEO | CI |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01/03/21 |
Director/Board Member | 67 | 01/01/21 | |
Richard Ridinger
CHM | Chairman | 66 | 01/03/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,09 % | 74,45 mil M | |
+11,35 % | 9180,02 M | |
+54,35 % | 5030,08 M | |
-12,85 % | 5021,85 M | |
+1,60 % | 3820,27 M | |
-20,85 % | 2409,95 M | |
+16,88 % | 2391,59 M | |
-29,25 % | 2274,04 M | |
+24,62 % | 2262,33 M |